Cargando…

Successful treatment of Candida albicans anterior chamber infection after penetrating keratoplasty

PURPOSE: To report the successful management of an anterior chamber (AC) infection after penetrating keratoplasty (PK) caused by Candida albicans. OBSERVATION: A 53-year-old female had a PK in her right eye. The donor rim tested positive for Candida albicans one week later. Despite initiation of pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Stunf Pukl, Spela, Herceg, Azra, Globočnik Petrovič, Mojca, Pfeifer, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899226/
https://www.ncbi.nlm.nih.gov/pubmed/35265779
http://dx.doi.org/10.1016/j.ajoc.2022.101466
_version_ 1784663868682797056
author Stunf Pukl, Spela
Herceg, Azra
Globočnik Petrovič, Mojca
Pfeifer, Vladimir
author_facet Stunf Pukl, Spela
Herceg, Azra
Globočnik Petrovič, Mojca
Pfeifer, Vladimir
author_sort Stunf Pukl, Spela
collection PubMed
description PURPOSE: To report the successful management of an anterior chamber (AC) infection after penetrating keratoplasty (PK) caused by Candida albicans. OBSERVATION: A 53-year-old female had a PK in her right eye. The donor rim tested positive for Candida albicans one week later. Despite initiation of prophylactic topical 1% voriconazole drops, the patient presented with a white mass in the anterior chamber one month later. Biopsy confirmed Candida. Antifungal therapy was intensified with the addition of intravenous fluconazole, and with repeated irrigations of the AC and intracameral administration of amphotericin B (off-label use). After two weeks of apparent lack of treatment response, the infection suddenly quiesced. The final outcome was visual acuity of 0.2 and a clear graft with an endothelial cell density of 2260 cells/mm. (2) CONCLUSIONS AND IMPORTANCE: Fungal intraocular infections after PK are usually devastating. Due to low intraocular penetration of topical antifungals, serial intracameral injections were used to maintain a therapeutic concentration of amphotericin B within the anterior chamber, and intravenous fluconazole was administered to protect against the spread of infection into the vitreous. A clinical response developed after two weeks. The reported case represents a favorable outcome using a multimodal approach.
format Online
Article
Text
id pubmed-8899226
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88992262022-03-08 Successful treatment of Candida albicans anterior chamber infection after penetrating keratoplasty Stunf Pukl, Spela Herceg, Azra Globočnik Petrovič, Mojca Pfeifer, Vladimir Am J Ophthalmol Case Rep Case Report PURPOSE: To report the successful management of an anterior chamber (AC) infection after penetrating keratoplasty (PK) caused by Candida albicans. OBSERVATION: A 53-year-old female had a PK in her right eye. The donor rim tested positive for Candida albicans one week later. Despite initiation of prophylactic topical 1% voriconazole drops, the patient presented with a white mass in the anterior chamber one month later. Biopsy confirmed Candida. Antifungal therapy was intensified with the addition of intravenous fluconazole, and with repeated irrigations of the AC and intracameral administration of amphotericin B (off-label use). After two weeks of apparent lack of treatment response, the infection suddenly quiesced. The final outcome was visual acuity of 0.2 and a clear graft with an endothelial cell density of 2260 cells/mm. (2) CONCLUSIONS AND IMPORTANCE: Fungal intraocular infections after PK are usually devastating. Due to low intraocular penetration of topical antifungals, serial intracameral injections were used to maintain a therapeutic concentration of amphotericin B within the anterior chamber, and intravenous fluconazole was administered to protect against the spread of infection into the vitreous. A clinical response developed after two weeks. The reported case represents a favorable outcome using a multimodal approach. Elsevier 2022-03-02 /pmc/articles/PMC8899226/ /pubmed/35265779 http://dx.doi.org/10.1016/j.ajoc.2022.101466 Text en © 2022 Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Stunf Pukl, Spela
Herceg, Azra
Globočnik Petrovič, Mojca
Pfeifer, Vladimir
Successful treatment of Candida albicans anterior chamber infection after penetrating keratoplasty
title Successful treatment of Candida albicans anterior chamber infection after penetrating keratoplasty
title_full Successful treatment of Candida albicans anterior chamber infection after penetrating keratoplasty
title_fullStr Successful treatment of Candida albicans anterior chamber infection after penetrating keratoplasty
title_full_unstemmed Successful treatment of Candida albicans anterior chamber infection after penetrating keratoplasty
title_short Successful treatment of Candida albicans anterior chamber infection after penetrating keratoplasty
title_sort successful treatment of candida albicans anterior chamber infection after penetrating keratoplasty
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899226/
https://www.ncbi.nlm.nih.gov/pubmed/35265779
http://dx.doi.org/10.1016/j.ajoc.2022.101466
work_keys_str_mv AT stunfpuklspela successfultreatmentofcandidaalbicansanteriorchamberinfectionafterpenetratingkeratoplasty
AT hercegazra successfultreatmentofcandidaalbicansanteriorchamberinfectionafterpenetratingkeratoplasty
AT globocnikpetrovicmojca successfultreatmentofcandidaalbicansanteriorchamberinfectionafterpenetratingkeratoplasty
AT pfeifervladimir successfultreatmentofcandidaalbicansanteriorchamberinfectionafterpenetratingkeratoplasty